Profile data is unavailable for this security.
About the company
Biosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). It operates through Fumouze Diagnostics and SR2B.
- Revenue in EUR (TTM)104.03m
- Net income in EUR-38.63m
- Incorporated2005
- Employees521.00
- LocationBiosynex SA22 Boulevard Sebastien BrantILLKIRCH-GRAFFENSTADEN 67400FranceFRA
- Phone+33 388787887
- Fax+33 388787678
- Websitehttps://www.biosynex.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Implanet SA | 7.30m | -6.91m | 16.12m | 41.00 | -- | 4.60 | -- | 2.21 | -0.1305 | -0.1226 | 0.0979 | 0.028 | 0.5227 | 0.7927 | 3.83 | 179,262.90 | -49.48 | -37.44 | -111.96 | -86.74 | 55.22 | 59.59 | -94.67 | -67.43 | 0.5906 | -14.51 | 0.5671 | -- | -7.24 | 2.08 | -88.59 | -- | -2.20 | -- |
| Ikonisys SA | 448.56k | -2.27m | 16.14m | 10.00 | -- | 0.8975 | -- | 35.98 | -0.233 | -0.233 | 0.0461 | 1.62 | 0.0211 | 1.18 | 32.21 | 44,856.00 | -10.65 | -- | -12.50 | -- | -20.88 | -- | -505.54 | -- | 0.0619 | -29.68 | 0.1244 | -- | -27.28 | -- | 7.38 | -- | -- | -- |
| Mauna Kea Technologies SA | 7.54m | -11.21m | 16.43m | 65.00 | -- | -- | -- | 2.18 | -0.2155 | -0.2155 | 0.1456 | -0.3148 | 0.3556 | 1.99 | 4.10 | 110,823.50 | -56.61 | -51.23 | -142.92 | -93.30 | 11.48 | 11.15 | -159.20 | -142.41 | 0.6603 | -12.87 | 3.50 | -- | 40.13 | 9.16 | 66.66 | -- | -21.16 | -- |
| Global Bioenergies SA | 486.06k | -7.36m | 16.69m | 45.00 | -- | 3.61 | -- | 34.33 | -0.4036 | -0.4036 | 0.0267 | 0.255 | 0.0276 | 5.06 | 0.4599 | 10,566.52 | -41.78 | -43.66 | -60.78 | -82.47 | -1,192.39 | -948.35 | -1,514.49 | -1,331.36 | 2.79 | -- | 0.5044 | -- | 365.83 | 36.25 | 27.78 | -- | -19.49 | -- |
| Theraclion SA | 1.28m | -3.56m | 17.33m | 28.00 | -- | 5.23 | -- | 13.51 | -0.0769 | -0.0769 | 0.0275 | 0.0719 | 0.0718 | -0.0103 | 1.03 | 44,235.86 | -19.94 | -32.98 | -26.41 | -48.01 | 102.48 | 60.85 | -277.68 | -249.16 | 2.69 | -- | 0.3303 | -- | 47.49 | -1.13 | 25.97 | -- | -7.23 | -- |
| Biosynex SA | 104.03m | -38.63m | 31.48m | 521.00 | -- | 0.2959 | -- | 0.3026 | -3.70 | -3.70 | 9.96 | 9.89 | 0.4326 | 0.5978 | 7.67 | 180,913.00 | -16.08 | 14.90 | -27.57 | 19.41 | 24.67 | 51.92 | -37.18 | 14.61 | 0.4005 | -12.58 | 0.3783 | -- | -52.70 | 24.40 | -337.76 | -- | -- | -- |
| AbL Diagnostics SA | 5.61m | 54.36k | 45.77m | 19.00 | 842.73 | 6.76 | 63.87 | 8.15 | 0.0034 | 0.0034 | 0.3483 | 0.42 | 0.3703 | -- | 1.42 | 295,411.60 | 0.3587 | 3.24 | 0.5884 | 4.43 | -- | -- | 0.9685 | 8.81 | 1.87 | -47.51 | 0.3389 | -- | -35.84 | 74.86 | -95.08 | -49.30 | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Sunny Asset Management SAas of 25 Oct 2024 | 75.00k | 0.70% |
| Financi�re Arbevel SAas of 30 Dec 2022 | 0.00 | 0.00% |
| MCA Finance SAas of 29 Dec 2023 | 0.00 | 0.00% |
| Lazard Asset Management LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| Mandarine Gestion SAas of 28 Jun 2024 | 0.00 | 0.00% |
| American Century Investment Management, Inc.as of 30 Sep 2024 | 0.00 | 0.00% |
